About
Diya Malhotra joined Abingworth in June 2021, having previously worked as a Consultant in L.E.K. Consulting's Life Sciences practice, where she advised pharmaceutical, biotech, and buyside clients on corporate strategy and clinical and commercial opportunity assessments. At Abingworth she works with the transatlantic investment team, particularly the Clinical Co-Development team, evaluating new opportunities and supporting existing investments. She holds a PhD in Clinical Neuropharmacology from Imperial College London and a degree in Pharmacology from University College London.
Invests in
Biotech
Experience
- AbingworthPrincipalcurrent2023 — presentGreater London, England, United Kingdom
- AbingworthInvestment Manager2021 — 2023Greater London, England, United Kingdom
- L.E.K. ConsultingLife Sciences Consultant2017 — 2021
Education
- Imperial College LondonDoctor of Philosophy (PhD), Neuroscience2013 — 2016
- University College LondonBSc Pharmacology, Neuropharmacology2010 — 2013
- Overseas Family School SingaporeInternational Baccalaureate Diploma
Skills & more
R&D1Stem Cells1In Vivo1In Vitro1Pharmacology2NeuroscienceResearch3Drug DiscoveryTraumatic Brain InjuryCell Culture1miRNAPatents
+12 more
Intellectual PropertyNeuropharmacologyProject ManagementAnaestheticsPublic EngagementData HandlingOrganotypic Hippocampal Slice CultureRT-PCRMentoringFluorescence MicroscopyFluorescence SpectroscopyMicrosoft OfficeFrom Diya's professional profile.
Same school
Shared employers
Also worked at Abingworth17
Carlos PayaVenture Partner at Ysios CapitalSarah ShackeltonAdvisor at Delin VenturesBali MuralidharGlobal Head of Life Sciences & CIO at AbingworthKurt von EmsterManaging Partner at AbingworthJayson PunwaniManaging Director, Head of Venture at AbingworthAndrew SinclairManaging Director, Head of Publics & Late Stage at Abingworth
+ 11 more
Also worked at L.E.K. Consulting117
Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures
.jpg)
+ 111 more
Colleagues at Abingworth
Alex Asquith
Counsel at Abingworth
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Ankur Shah
Vice President, CCD at Abingworth
Anna Slezak
Senior Associate at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Carlos Paya
Venture Partner at Abingworth
Dayle Hogg
Operating Executive at Abingworth
Elizabeth O'Brien
Executive Assistant at Abingworth
Network5
Andrew Sinclair
Managing Director, Head of Publics & Late Stage at Abingworth
Bali Muralidhar
Global Head of Life Sciences & CIO at Abingworth
Genghis Lloyd-Harris
Senior Advisor at Abingworth
Jacqueline Grant
Principal at Abingworth
Jay Cui
Principal at Abingworth
Investors connected to Diya in public investor directories — a warm-intro map.